Tilray Brands, Inc.
-18.2% · 90d
$6.89
+0.14 (+2.07%)
After-Hours $6.88(-0.01)
News
(1)April 2026
Tilray Brands, Inc. — 8-K Filing
TLRYTilray Brands, Inc.
# 🧾 What This Document Is This is an **8-K filing**, which companies use to announce major news to investors. Attached is their **press release** for the third quarter of fiscal year 2026 (the quarter ending February 28, 2026). It’s a detailed report card on how the business performed over the last
Read summaryView on SEC EDGAR
Peers in Drug Manufacturers - Specialty & Generic
TAK#1
Takeda Pharmaceutical Company Limited
$57.78B-1.07%
ZTS#2
Zoetis Inc.
$50.46B+0.20%
HLN#3
Haleon plc
$43.61B+0.40%
TEVA#4
Teva Pharmaceutical Industries Limited
$36.05B+1.44%
UTHR#5
United Therapeutics Corporation
$25.19B-1.19%
VTRS#6
Viatris Inc.
$15.85B+0.29%
RGC#7
Regencell Bioscience Holdings Limited
$13.93B-2.46%
NBIX#8
Neurocrine Biosciences, Inc.
$13.21B-1.13%
ELAN#9
Elanco Animal Health Incorporated
$11.66B-0.59%
RDY#10
Dr. Reddy's Laboratories Limited
$10.92B+0.15%